Natural anti-GBM antibodies from normal human sera recognize α3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease

被引:37
|
作者
Yang, Rui
Cui, Zhao
Hellmark, Thomas
Segelmark, Marten
Zhao, Ming-hui [1 ]
Wang, Hai-yan
机构
[1] Peking Univ, Inst Nephrol, Peking Univ Hosp 1,Minist Hlth China, Dept Med,Renal Div,Key Lab Renal Dis, Beijing 100034, Peoples R China
[2] Lund Univ, Dept Nephrol, SE-22184 Lund, Sweden
关键词
natural anti-GBM antibody; antigen specificity; epitope mapping;
D O I
10.1016/j.clim.2007.05.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-GBM disease is a rare autoimmune condition characterized by autoantibodies targeting the alpha 3 chain non-collagen 1 domain of type IV collagen (alpha 3(IV)NC1). Recently, we isolated IgG reacting with alpha 3(IV)NC1 from normal healthy human sera. The current study examined the antigen and epitope specificity of these natural autoantibodies (NAA) using recombinant human alpha 1, 3, 5(IV)NC1 and three constructs expressing, previously defined epitope regions designated E-A, E-B and S2, in the alpha 1(IV)NC1 background. The NAA preparations reacted with recombinant human alpha 3(IV) NC1 to the same extent as with purified bovine alpha(IV)NC1, but not with recombinant human alpha 1 and alpha 5 (IV)NC1. NAA preparations recognized the three chimeric proteins (E-A, E-B and S2) yielding similar absorbance values. We conclude that anti-GBM NAA recognize the same major epitopes as anti-GBM antibodies from patients with Goodpasture's disease. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 50 条
  • [21] EPITOPE SPECIFICITY OF ANTI-GBM ANTIBODIES DEMONSTRATED WITH SYNTHETIC PEPTIDES
    HELLMARK, T
    BRUNMARK, C
    TROJNAR, J
    WIESLANDER, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 832 - 832
  • [22] ANTI-GBM ANTIBODIES IN CRESCENTIC NEPHRITIS WITHOUT KIDNEY BINDING
    Sadeghi-Alavijeh, Omid
    Henderson, Scott
    Bass, Paul
    de Groot, Kirsten
    Salama, Alan D.
    RHEUMATOLOGY, 2017, 56 : 82 - 83
  • [23] Anti-GBM disease in XenoMouse II is induced by human MAb versus α3(IV)NC1 collagen.
    Meyers, KEC
    Allen, J
    Gehret, J
    Gallo, M
    Hopfer, H
    Kalluri, R
    Madaio, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) : A24 - A24
  • [24] Epitope specificity of anti-GBM antibodies demonstrated with synthetic peptides
    Hellmark, T
    Brunmark, C
    Trojnar, J
    Wieslander, J
    KIDNEY INTERNATIONAL, 1996, 49 (03) : 927 - 927
  • [25] Clinical features and outcome of patients with both ANCA and anti-GBM antibodies
    Levy, JB
    Hammad, T
    Coulthart, A
    Dougan, T
    Pusey, CD
    KIDNEY INTERNATIONAL, 2004, 66 (04) : 1535 - 1540
  • [26] Outcome of Renal Transplantation in Patients With Both ANCA and Anti-GBM Antibodies
    Raman, Gaurav
    Srivastava, Amar
    Geetha, Duvuru
    TRANSPLANTATION, 2012, 94 (05) : E30 - E31
  • [27] TRANSFER OF SIGNIFICANT OR PROGRESSIVE ANTI-GBM NEPHRITIS (AGN) IN SHEEP BY PLASMA ANTI-GBM AUTOANTIBODIES (AAB) FROM NEPHRITIC SHEEP
    STEBLAY, RW
    RUDOFSKY, U
    KIDNEY INTERNATIONAL, 1985, 27 (01) : 223 - 223
  • [28] Induction of anti-GBM nephritis in rats by recombinant α3(IV)NC1 and α4(IV)NC1 of type IV collagen
    Sado, Y
    Boutaud, A
    Kagawa, M
    Naito, I
    Ninomiya, Y
    Hudson, BG
    KIDNEY INTERNATIONAL, 1998, 53 (03) : 664 - 671
  • [29] Alloantibodies to alpha 5(IV)NC1 in Alport post-transplant anti-GBM disease.
    Turner, AN
    Brainwood, D
    Gubler, MC
    Kashtan, CE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2385 - A2385
  • [30] Comparative evaluation of anti-PR3, anti-MPO and anti-GBM EIA assays for the detection of ANCA and antibodies to GBM
    Lerner, Raisa
    Kumfert, Wen
    Vandam, Wendy
    Guo, Xiaowen
    Prestigiacomo, Tony
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 88 - 89